Intrexon | XON - Ebit

Preço das Ações
4.16
Mudança Diária
-0.11 -2.58%
Mensal
21.64%
Anual
197.14%
Q2 Previsão
4.05




Ebit Alterar Data
Agenus USD 14.4M 19.26M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.96B 464M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Intrexon USD -26.3M 2.91M 2024-06
Karyopharm Therapeutics USD -17.84M 8.44M 2025-12
Ligand Pharmaceuticals USD 158.89M 115.32M 2025-09
MacroGenics USD -12.1M 32.26M 2025-12
MannKind USD -69.24M 28.19M 2025-12
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Roche Holding CHF 9.56B 2.1B 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Veracyte USD 24.63M 1.52M 2025-12
Xencor USD -53.63M 6.11M 2025-12